Matheus van Rens

Matheus van Rens

Auto-generated profile, based on publicly available information

Matheus van Rens

Neonatal Intensive Care Unit, Radboud University Medical Center, Amalia Children’s Hospital, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2016 in The Journal of Vascular Access
Verified
Journal Article
Closed access
MLMonique Legemaat
Monique Legemaat
Peter CarrPeter Carr
Peter Carr
RRRoland M. van Rens
Roland M. van Rens
MDMonique Hoogleraar Verplegingswetenschap Van Dijk
Monique Hoogleraar Verplegingswetenschap Van Dijk
IPIrina E. Poslawsky
Irina E. Poslawsky
AHAgnes van Den Hoogen
Agnes van Den Hoogen
Introduction: Neonates admitted to a neonatal intensive care unit (NICU) rely highly on intravenous (IV) therapy, for which the peripheral intravenous cannula (PIVC) is the preferred device to allow such therapies to proceed. Placement of a PIVC is a painful procedure and repeated attempts for successful insertion should therefore be limited. We aimed to quantify the incidence, complications, and factors associated with these complications. Methods: We conducted a prospective observational study to examine PIVC-related complications in level III NICUs of two university medical centers (UMC) in The Netherlands. We performed descriptive analyses and binary logistic regression analysis to identify factors associated with PIVC complications. Results: A total of 518 catheters were inserted in 235 infants. The first-time success rate was 45%. The predominant reason for non-elective removal due to complications was infiltration (N = 193; 67%). No significant association was found between discipline of the inserter, vein visualization device and location of the PIVC and whether or not a catheter needed to be removed due to a complication. Conclusions: In this study the majority of PIVCs were removed after the occurrence of a complication. The most common complication was infiltration. Strategies to identify and prevent infiltration in an NICU population are required. Future interventional studies should attempt to improve first-time insertion success and reduce PIVC failure from infiltration in the neonate. Based on the results of the present study, neonatologists and physician assistants are the preferential PIVC inserters. Advanced training of all members of vascular access specialist teams and ongoing monitoring of PIVC-related complications are recommended.

24 October 2024 in The Journal of Vascular Access
Verified
Journal Article
Closed access
MRMatheus (Roland) van Rens
Matheus (Roland) van Rens
RLRobin van der Lee
Robin van der Lee
TSTimothy Spencer
Timothy Spencer
TBTon van Boxtel
Ton van Boxtel
Giovanni BaroneGiovanni Barone
Giovanni Barone
O(on behalf of the WoCoVA Foundation (World Conference on Vascular Access) and of the Global Vascular Access Network (GloVANet)
on behalf of the WoCoVA Foundation (World Conference on Vascular Access) and of the Global Vascular Access Network (GloVANet)
The field of vascular access has witnessed significant advancements in recent years, improving healthcare delivery across various patient populations through the use of diverse intravascular access devices. Despite these innovations, a critical issue remains: the lack of a globally standardized set of descriptors for these devices. This gap impedes clear communication and coordination within the healthcare community. Recognizing the necessity for standardized terminology, the Global Vascular Access Network (GloVANet), in collaboration with the World Congress of Vascular Access (WoCoVA), initiated the NAVIGATE project ( N omencl A ture V ia I ntegrated G lobal A dvancements in T erminology E fficiencies). The aim of the project is to propose a clear and practical nomenclature for current vascular access devices, encompassing both central, peripheral venous, and arterial access devices. A panel of international vascular access experts from several clinical domains was selected by the Scientific Committee of WoCoVA to develop a position statement around vascular access device nomenclature. Following a comprehensive literature review, a consensus was reached using a modified Delphi process. The outcome of this collaborative effort is a WoCoVA/GloVANet position statement, which provides standardized nomenclature for vascular access devices. The adoption of unified terminology brings several benefits, firstly, it ensures clarity, reproducibility, and comparability when reporting in clinical studies, and secondly, reduces ambiguous or imprecise terms in communication between healthcare professionals in clinical practice.

3 November 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
MRMatheus F. P. T. van Rens
Matheus F. P. T. van Rens
MBMohammad A. A. Bayoumi
Mohammad A. A. Bayoumi
AHAgnes van de Hoogen
Agnes van de Hoogen
AFAirene L. V. Francia
Airene L. V. Francia
ICIrian J. Cabanillas
Irian J. Cabanillas
TSTimothy Spencer
Timothy Spencer
Background: Venous access devices (VADs) play a vital role within the neonatal intensive care unit. However, there are significant risks associated with the use of VADs, with complications such as infection, thrombosis, device occlusion, and infiltration/extravasation frequently contributing to device-related failures and increasing the risk of significant patient harm or injury. This study aimed to explore the relationships between risk factors and different venous access device complications in the neonatal setting, and then use that evidence to develop an algorithm based on observational data.Methods: This is a retrospective, single-center cohort study that was conducted in a large 112-bed neonatal intensive care unit in Qatar. We examined venous access device data from January 2016 to December 2018 for all term and preterm neonates. Descriptive statistics were used to summarize the outcomes, which included a mean and its standard deviation or median and an interquartile range for continuous variables regarding normal distribution, and absolute numbers with percentages for discrete variables.Results: The authors recorded a total of 23,858 VADs inserted during the study period. Of these, 21,313 (89%) were peripheral intravenous catheters, 689 (3%) were extended dwell-peripheral intravenous catheters, 1,335 (6%) were epicutaneo-caval catheters, and 521 (2%) were umbilical venous catheters. In total, 51,179 catheter days were registered, with 2.17 catheter days reported per patient. Peripheral device dwell times were significantly shorter when compared with central venous catheter devices (P < 0.001), with mean dwell times of 22 days ± 23 h and 236 days ± 183 h, respectively. After insertion, a complication occurred in 11,177 (51%) of peripheral VADs and 221 (12%) of central VADs. The type of device inserted [P < 0.001, hazard ratio (HR) = 0.52, 95% confidence interval (CI): 0.50–0.54], reason/indication for intravenous therapy (P < 0.001, HR = 0.85, 95% CI: 0.82–0.87), and the side of insertion of the device (P < 0.001, HR = 1.25, 95% CI: 1.24–1.27) had a significant relationship with outcomes.Conclusions: Four subgroups of VADs were identified (peripheral intravenous catheters, extended dwell-peripheral intravenous devices, epicutaneo-caval catheters, and umbilical venous catheters) with outcome-related differences. Central venous access devices (epicutaneo-caval catheters and umbilical venous catheters) had lower complications compared with peripheral VADs. Proper venous access device selection, early insertion, and early removal approaches remain crucial to preventing venous access device complications. Peripheral intravenous devices should be used carefully and closely watched for early detection of complications.

30 June 2020 in The Journal of Vascular Access
Verified
Journal Article
Open access
PDF file
MBMohammad A A Bayoumi
Mohammad A A Bayoumi
MRMatheus F P Van Rens
Matheus F P Van Rens
PCPrem Chandra
Prem Chandra
AFAirene L V Francia
Airene L V Francia
SDSunitha D’souza
Sunitha D’souza
ICIrian J E Cabanillas
Irian J E Cabanillas
Background: Until the 1980s, central vascular access in the Neonatal Intensive Care Unit was predominantly delivered by umbilical catheters and only and if needed by surgical cutdowns or subclavian vein catheterization through blind percutaneous venipuncture. In the early 1980s, epicutaneo-caval catheters were successfully introduced. Methods: In our Neonatal Intensive Care Unit, a dedicated team to insert epicutaneo-caval catheters was formally established in January 2017, including 12 neonatologists and 1 neonatal nurse practitioner. A before- versus after-intervention study was designed to determine whether the establishment of the epicutaneo-caval catheter insertion team is associated with increased success rates and a decreased risk of catheter-related complications. Success rates and other catheter-related parameters were traced from 2016 onward. Collected data were analyzed for three consecutive years: 2016, 2017, and 2018. Results: The epicutaneo-caval catheter team inserted 1336 catheters over 3 years. Both first prick (from 57.7% to 66.9%; p = 0.023) and overall success (from 81.7% to 97.6%; p < 0.0001) rates significantly improved. In 2018, the number of tunneled or surgically inserted central venous catheters came down to zero (p < 0.0001). Overall catheter-related complications were significantly lower following the epicutaneo-caval catheter team’s establishment (p < 0.0001) while there was no significant decrease noted (p = 0.978) in central line–associated bacterial stream infection rates. Conclusion: A dedicated epicutaneo-caval catheter team is a promising intervention to increase success rates and significantly decrease catheter-related complications in Neonatal Intensive Care Unit. Standardizing epicutaneo-caval catheter placement is important; however, standardizing catheter maintenance seems essential to the improvement of central line–associated bacterial stream infection rates.

1 May 2015 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
MLMonique M. Legemaat
Monique M. Legemaat
IJIrene P. Jongerden
Irene P. Jongerden
RRRoland M.F.P.T. van Rens
Roland M.F.P.T. van Rens
MZMarjanne Zielman
Marjanne Zielman
AHAgnes van Den Hoogen
Agnes van Den Hoogen

16 February 2023 in The Journal of Vascular Access
Verified
Journal Article
Open access
MRMatheus Fpt van Rens
Matheus Fpt van Rens
TSTimothy Spencer
Timothy Spencer
KHKevin Hugill
Kevin Hugill
AFAirene Lv Francia
Airene Lv Francia
FLFredericus HJ Van Loon
Fredericus HJ Van Loon
MBMohammad Aa Bayoumi
Mohammad Aa Bayoumi
Background: Evidence-based insertion and maintenance strategies for neonatal vascular access devices (VAD) exist to reduce the causes of VAD failure and complications in neonates. Peripheral intravenous catheter failure and complications including, infiltration, extravasation, phlebitis, dislodgement with/without removal, and infection are majorly influenced by catheter securement methods. Methods: A retrospective, observational study using routinely collected data on intravenous device use in a large neonatal intensive care unit in Qatar. A 6-month historical cohort was compared with a 6-month cohort after the introduction of an octyl-butyl-cyanoacrylate glue (CG). In the historical cohort, the catheter was secured using a semi-permeable transparent membrane dressing while in the CG cohort, CG was applied at the insertion site on initial insertion and after any dressing change. This was the only variable intervention between both groups. Results: A total of 8330 peripheral catheters were inserted. All catheters were inserted and monitored by members of the NeoVAT team. 4457 (53.5%) were secured with just a semi-permeable transparent dressing and 3873 (46.5%) secured a semi-permeable transparent dressing with the addition of CG. The odds ratio for premature failure after securement with CG was 0.59 (0.54–0.65) when compared to the catheters secured with a semi-permeable transparent dressing, which was statistically significant ( p < 0.001). The correlation between the occurrence of a complication and the use of CG for device securement was significant ( p < 0.001). Conclusions: The risk of developing device-related phlebitis and premature device removal, increased significantly if CG was not used for adjunct catheter securement. In parallel with the currently published literature, this study’s findings support the use of CG for vascular device securement. When device securement and stabilization concerns are most pertinent CG is a safe and effective adjunct to reducing therapy failures in the neonatal patient population.